2026

Iaconelli, A. et al. (2026) Cancer and heart failure: prevalence, incidence, and prognosis in Scotland. European Heart Journal, (doi: 10.1093/eurheartj/ehag120) (PMID:42068332) (Early Online Publication)

Ferreira, João Pedro, Marques, Pedro, Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464 and Anker, Markus S. (2026) Beyond chronological age: why frailty matters in heart failure. European Journal of Heart Failure, (doi: 10.1093/ejhf/xuag145) (PMID:42048566) (Early Online Publication)

Bewarder, Yvonne, Zimmer, Angela, Anker, Markus, Anker, Stefan, Christofyllakis, Konstantinos, Bewarder, Moritz, Schwantke, Igor and Böhm, Michael (2026) Effect of heart rate reduction with ivabradine on quality of life in advanced cancer patients. ESC Heart Failure, 13(2), xvag051. (doi: 10.1093/eschf/xvag051) (PMID:41914026) (PMCID:PMC13036374)

2025

Anker, M. S. et al. (2025) Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: rationale and design of the EMPATICC trial. European Journal of Heart Failure, 27(10), pp. 1905-1917. (doi: 10.1002/ejhf.3799) (PMID:40857084) (PMCID:PMC12575421)

Keramida, K. et al. (2025) Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio‐Oncology. European Journal of Heart Failure, (doi: 10.1002/ejhf.70005) (PMID:40938778) (Early Online Publication)

Anker, M. S. et al. (2025) Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer. European Journal of Heart Failure, (doi: 10.1002/ejhf.3744) (PMID:40767389) (Early Online Publication)

Anker, S. D. et al. (2025) Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure ( FAIR ‐ HF2 ‐ DZHK05 ) trial: baseline characteristics and comparison to other relevant clinical trials. European Journal of Heart Failure, 27(8), pp. 1436-1443. (doi: 10.1002/ejhf.3658) (PMID:40300786) (PMCID:PMC12482851)

Stolfo, D. et al. (2025) How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. European Journal of Heart Failure, 27(5), pp. 747-759. (doi: 10.1002/ejhf.3642) (PMID:40091554) (PMCID:PMC12103960)

Articles

Iaconelli, A. et al. (2026) Cancer and heart failure: prevalence, incidence, and prognosis in Scotland. European Heart Journal, (doi: 10.1093/eurheartj/ehag120) (PMID:42068332) (Early Online Publication)

Ferreira, João Pedro, Marques, Pedro, Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464 and Anker, Markus S. (2026) Beyond chronological age: why frailty matters in heart failure. European Journal of Heart Failure, (doi: 10.1093/ejhf/xuag145) (PMID:42048566) (Early Online Publication)

Bewarder, Yvonne, Zimmer, Angela, Anker, Markus, Anker, Stefan, Christofyllakis, Konstantinos, Bewarder, Moritz, Schwantke, Igor and Böhm, Michael (2026) Effect of heart rate reduction with ivabradine on quality of life in advanced cancer patients. ESC Heart Failure, 13(2), xvag051. (doi: 10.1093/eschf/xvag051) (PMID:41914026) (PMCID:PMC13036374)

Anker, M. S. et al. (2025) Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: rationale and design of the EMPATICC trial. European Journal of Heart Failure, 27(10), pp. 1905-1917. (doi: 10.1002/ejhf.3799) (PMID:40857084) (PMCID:PMC12575421)

Keramida, K. et al. (2025) Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio‐Oncology. European Journal of Heart Failure, (doi: 10.1002/ejhf.70005) (PMID:40938778) (Early Online Publication)

Anker, M. S. et al. (2025) Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer. European Journal of Heart Failure, (doi: 10.1002/ejhf.3744) (PMID:40767389) (Early Online Publication)

Anker, S. D. et al. (2025) Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure ( FAIR ‐ HF2 ‐ DZHK05 ) trial: baseline characteristics and comparison to other relevant clinical trials. European Journal of Heart Failure, 27(8), pp. 1436-1443. (doi: 10.1002/ejhf.3658) (PMID:40300786) (PMCID:PMC12482851)

Stolfo, D. et al. (2025) How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. European Journal of Heart Failure, 27(5), pp. 747-759. (doi: 10.1002/ejhf.3642) (PMID:40091554) (PMCID:PMC12103960)